Quantcast

Latest Tumor markers Stories

2014-04-08 12:26:42

LONDON, April 8, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:2014 Opportunities in the US Endocrine Function Testing MarketThis new 271-page report from Venture Planning Group provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and...

New Prostate Cancer Test May Remove The Need For Painful Biopsies
2014-04-08 09:00:53

April Flowers for redOrbit.com - Your Universe Online Globally, over one million men a year have prostate tissue samples taken to check for signs of prostate cancer. This procedure can involve up to 12 large biopsy needles and has been called barbaric by Mayo Graduate School of Medicine Professor Matthew Gettman. As well, it reveals that 70 percent of the men undergoing the procedure do not have cancer. Beyond being unnecessarily painful and risky for the patient, the procedure is...

2014-04-04 12:23:54

These genes could explain why some women with high-risk mutations suffer from cancer while others do not Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. Spanish National Cancer Research Centre (CNIO) researchers are conducting a study that will contribute towards giving every woman far...

2014-03-26 23:25:49

Fulgent Diagnostics announces a clinical BRCA1/BRCA2 full gene sequencing test for $500. Temple City, California (PRWEB) March 26, 2014 In addition to the BRCA1/BRCA2 full gene sequencing test, Fulgent Diagnostics has also added a gene rearrangement test for an additional cost of $400. Fulgent Diagnostic's BRCA1/BRCA2 full gene sequencing test with rearrangement provides valuable information that can lead to potential treatment options that could mitigate certain risks. These options...

2014-03-19 23:04:03

A study published in last month’s Journal of Clinical Oncology suggests that women with the BRCA1 gene mutation may significantly reduce their chances of ovarian cancer if they have their ovaries removed by age 35. Abington, PA (PRWEB) March 19, 2014 Among study participants who underwent oophorectomy (ovary removal surgery), their chances of ovarian and breast cancers decreased by 80 percent. Additionally, their risk of death from any cause by age 70 decreased 77 percent as a result of...

2014-03-12 11:43:12

The gene known to be associated with breast cancer susceptibility, BRCA 1, plays a critical role in the normal metabolic function of skeletal muscle, according to a new study led by University of Maryland School of Public Health researchers. Dr. Espen Spangenburg, associate professor of kinesiology, and his laboratory team are the first to identify that the BRCA1 protein is expressed in the skeletal muscle of both mice and humans, and that it plays a key role in fat storage, insulin response...

2014-02-27 16:26:09

COMBINING SCIENCE AND ART, THE SCULPTURE ECHOES THE OPTIMISM SURROUNDING RECENT BREAKTHROUGHS IN BREAST CANCER RESEARCH NEW YORK, Feb. 27, 2014 /PRNewswire/ -- On March 12, 2014, the Basser Research Center for BRCA, at the Ruth and Raymond Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania, will unveil "Homologous Hope," a dramatic sculpture commissioned from internationally renowned artist Mara G. Haseltine. http://photos.prnewswire.com/prnvar/20140227/NY73843 An...

2014-02-26 12:25:59

New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb. 26, 2014 /PRNewswire-USNewswire/ -- Northwestern Medicine(®) is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test's accuracy will effectively remove the...

2014-01-27 08:27:47

MOUNTAIN VIEW, Calif., Jan. 27, 2014 /PRNewswire/ -- Dr. Shinji Satomura, President, and Dr. Henry Wada, CSO of Wako Life Sciences, Inc., received an award from the Northern California Section of AACC for the scientific and technology contribution to clinical chemistry achieved by the development of the uTASWako i30 Immunoanalyzer. (Photo: http://photos.prnewswire.com/prnh/20140127/LA52677) (Logo: http://photos.prnewswire.com/prnh/20130729/LA53779LOGO-b) "Wako is happy to receive...

2014-01-24 13:26:27

In laboratory experiments conducted on human cell lines at the Johns Hopkins Kimmel Cancer Center, scientists have shown that people carrying certain mutations in two hereditary cancer genes, BRCA2 and PALB2, may have a higher than usual susceptibility to DNA damage caused by a byproduct of alcohol, called acetaldehyde. The scientists say they suspect that the two genes in their normal forms evolved to protect cells against the damaging effects of acetaldehyde, which can lead to cancer....


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related